Panax notoginseng saponins inhibits NLRP3 inflammasome-mediated pyroptosis by downregulating lncRNA-ANRIL in cardiorenal syndrome type 4
Abstract Objective Cardiorenal syndrome type 4 (CRS4) is a complication of chronic kidney disease. Panax notoginseng saponins (PNS) have been confirmed to be efficient in cardiovascular diseases. Our study aimed to explore the therapeutic role and mechanism of PNS in CRS4. Methods CRS4 model rats an...
Saved in:
Main Authors: | Ying Xu (Author), Luxi Cao (Author), Wenli Zou (Author), Rizhen Yu (Author), Wei Shen (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Saponin accumulation in the seedling root of <it>Panax notoginseng</it>
by: Zhang Yingjun, et al.
Published: (2011) -
Pustular drug eruption due to Panax notoginseng saponins
by: Yin ZQ, et al.
Published: (2014) -
Stereoisomers of Saponins in Panax notoginseng (Sanqi): A Review
by: Ming Peng, et al.
Published: (2018) -
High-throughput transcriptional profiling of perturbations by Panax ginseng saponins and Panax notoginseng saponins using TCM-seq
by: Junyun Cheng, et al.
Published: (2023) -
Integrated metabolomic and transcriptomic analyses revealed the distribution of saponins in Panax notoginseng
by: Guangfei Wei, et al.
Published: (2018)